QLT Inc.
Edit Page
Report
Scan day: 05 February 2014 UTC
5
Virus safety - good
Description: Develops pharmaceutical products for use in photodynamic therapy (PDT), using light-activated drugs to treat disease. (Nasdaq: QLTI).
QLT Announces First Patient Dosed in Phase IIa Proof-of-Concept Trial for QLT091001 in Impaired Dark Adaptation QLT Announces Oral Retinoid Program Clinical and Regulatory Update, and Review of Strategic Alternatives
Size: 216 chars
Contact Information
Email: —
Phone&Fax: 877.764.3131
Address: —
Extended: —
WEBSITE Info
| Page title: | QLT Inc. |
| Keywords: | |
| Description: | |
| IP-address: | 207.194.156.1 |
WHOIS Info
| NS | Name Server: NS1.QLTINC.COM Name Server: NS2.QLTINC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 13-may-1999 Expiration Date: 13-may-2015 |